stoxline Quote Chart Rank Option Currency Glossary
  
Eupraxia Pharmaceuticals Inc. Common Stock (EPRX)
3.1  0.6 (24%)    11-01 16:00
Open: 2.56
High: 3.79
Volume: 207,674
  
Pre. Close: 2.5
Low: 2.5
Market Cap: 110(M)
Technical analysis
2024-11-01 4:44:27 PM
Short term     
Mid term     
Targets 6-month :  4.42 1-year :  5.17
Resists First :  3.78 Second :  4.42
Pivot price 2.5
Supports First :  2.8 Second :  2.2
MAs MA(5) :  2.63 MA(20) :  2.48
MA(100) :  2.6 MA(250) :  0
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  47.8 D(3) :  49.4
RSI RSI(14): 70.3
52-week High :  3.78 Low :  2.2
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ EPRX ] has closed It is unclear right now based on current values. 63.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.79 - 3.81 3.81 - 3.82
Low: 2.47 - 2.48 2.48 - 2.5
Close: 3.08 - 3.1 3.1 - 3.12
Company Description

Headline News

Thu, 31 Oct 2024
Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million - StockTitan

Fri, 02 Aug 2024
Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility - Canada NewsWire

Sun, 03 Nov 2024

Sun, 03 Nov 2024

Sun, 03 Nov 2024

Sun, 03 Nov 2024

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 36 (M)
Shares Float 30 (M)
Held by Insiders 6.9 (%)
Held by Institutions 12.8 (%)
Shares Short 128 (K)
Shares Short P.Month 128 (K)
Stock Financials
EPS -0.94
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.41
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -98.7 %
Return on Equity (ttm) -314.5 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.9
Qtrly Earnings Growth 0 %
Operating Cash Flow -26 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio -3.34
PEG Ratio 0
Price to Book value 7.38
Price to Sales 0
Price to Cash Flow -4.3
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android